LuciTuca

LuciTuca uses and dosage

LuciTuca (Tucatinib), generic Tukysa is a prescription medicine used to treat locally advanced unresectable or metastatic HER2-positive breast cancer who have received at least one or more prior anti-HER2 treatment regimens. Tucatinib is indicated in combination with trastuzumab and capecitabine medicine. LuciTuca manufactured by Lucius Pharma Ltd. In Laos. Tucatinib has to take orally 300mg twice daily with or without food (about 12 hours apart).

LuciTuca side effects

The most common adverse reactions of Tucatinib are: Diarrhea, hand-foot syndrome, nausea, fatigue, liver problems, vomiting, mouth sores/ pain, weight loss, muscle/ joint pain, loss of appetite, abdominal pain, headache, anemia, rash.

Originator brand

Tukysa by Seagen Inc

Made by

Lucius Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.